Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats.
about
Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardiaPPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathwayEffect of lifestyle intervention plus rosiglitazone or placebo therapy on left ventricular mass assessed with cardiovascular magnetic resonance in the metabolic syndrome.Randomized comparison of the effects of rosiglitazone vs. placebo on peak integrated cardiovascular performance, cardiac structure, and functionEndogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism.Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitroSuppression of cardiac myocyte hypertrophy by conjugated linoleic acid: role of peroxisome proliferator-activated receptors alpha and gamma.Cardiovascular effects of the thiazolidinediones.PPAR-gamma in the Cardiovascular SystemRoles of PPARs on regulating myocardial energy and lipid homeostasis.Peroxisome proliferator-activated receptors and inflammation: take it to heart.PPAR-gamma expression in animals subjected to volume overload and chronic Urotensin II administration.Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.PPARgamma as a potential therapeutic target in pulmonary hypertension.Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection.Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy.Activation of PPARgamma by pioglitazone does not attenuate left ventricular hypertrophy following aortic banding in rats.The inhibitory effects of rosiglitazone on cardiac hypertrophy through modulating the renin-angiotensin system in diet-induced hypercholesterolemic rats.Long-term effects of the PPAR gamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats.Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats.Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.Apigenin Attenuates β-Receptor-Stimulated Myocardial Injury Via Safeguarding Cardiac Functions and Escalation of Antioxidant Defence System.Activation of peroxisome proliferator-activated receptor-alpha and -gamma in auricular tissue from heart failure patients.
P2860
Q28569783-29969C15-550A-48F6-AD8C-351715EB47CFQ28574163-D8D110FD-571E-4436-8BB6-1284C0D630CEQ28580167-A85E908D-FEBD-4DBE-8DC8-EAC21313E217Q30472847-D92DE2CD-C2F9-4DBD-B36B-042AEB3D9464Q34123775-9E110587-D639-4F52-A080-0A4C8A6248FDQ34150535-1156EE08-EFAF-472E-A0B9-302CAEC2803CQ34576530-07BDD89A-E35D-4744-83B7-A47E5D5DBBF9Q34751805-F8AD2FC3-D014-4B42-9C7B-41F731BAE8BDQ36268105-5916931D-ABEC-49D7-AB95-3EE62EDC6635Q36426786-98D23323-B969-4203-83B7-ACA9A28FB16EQ36759083-79ABFDBB-4611-4E7A-A75F-FD57AE09E3C5Q36970664-324DE6FF-C8B9-44C5-B168-BB904CAF18BFQ37422701-AAD08076-6533-4D89-BD15-18F5981F4DD1Q37474984-51E8954F-068F-4651-B379-BD517D01413EQ37689190-B2F79DFE-36D8-406B-AC3C-88EAC1C2D6A7Q38640842-D64B6098-7DB0-4C6E-95A6-FBCEB0CA4687Q39598383-57B17E67-2DA7-4E40-A0F0-8509F94ADD96Q42834790-D51D8228-F1E4-46EC-A918-823BB3427CE1Q42859670-293C11F7-F66B-496B-BF76-112B6D9B92BDQ43036719-F032A2B9-07EC-44CD-820E-6D634057E6F4Q43182357-E8818F91-660E-4A8A-8FB6-3936529C8BF9Q43210917-9DA0DC80-5BBD-4F1C-A7A1-8F35A05B4976Q45220355-815AE5D2-CD3D-4D27-9FBE-05EAA9CD2B97Q46906334-B0CE30B5-123E-436A-8B9E-31FDE2B0B85AQ50691502-A0910164-6DFE-4123-B760-08FA8A60A34BQ53420523-082F7A56-1D4C-4C9A-8DF5-D6A16096DBEEQ54640549-583CAF7A-9CFD-4124-9C8B-6381C20DC79F
P2860
Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Peroxisome proliferator-activa ...... d cardiac hypertrophy in rats.
@en
Peroxisome proliferator-activa ...... d cardiac hypertrophy in rats.
@nl
type
label
Peroxisome proliferator-activa ...... d cardiac hypertrophy in rats.
@en
Peroxisome proliferator-activa ...... d cardiac hypertrophy in rats.
@nl
prefLabel
Peroxisome proliferator-activa ...... d cardiac hypertrophy in rats.
@en
Peroxisome proliferator-activa ...... d cardiac hypertrophy in rats.
@nl
P2093
P356
P1433
P1476
Peroxisome proliferator-activa ...... d cardiac hypertrophy in rats.
@en
P2093
Iwao Yamaguchi
Katsutoshi Goto
Satoshi Sakai
Takashi Miyauchi
Takehiro Ogata
Yoko Irukayama-Tomobe
P304
P356
10.1042/CS103S016S
P407
P478
103 Suppl 48
P577
2002-08-01T00:00:00Z